Please login to the form below

Not currently logged in
Email:
Password:

Biogen Idec appoints senior neuroscientists

Christopher Henderson and Richard Ransohoff make the move from academia

Biogen Idec Chris HendersonBiogen Idec has boosted its senior neuroscience research team with the addition of two university professors.

Dr Christopher Henderson (top right) joins from Columbia University as vice president, neurology and Dr Richard Ransohoff (bottom right) arrives from the Cleveland Clinic as senior research fellow, neuroimmunology.

The two will help lead Biogen Idec's research efforts across neurodegenerative and neuroimmune diseases, including Alzheimer's disease, Parkinson's disease, amyotrophic lateral sclerosis (ALS) and multiple sclerosis (MS).

Both will report directly to Dr Spyros Artavanis-Tsakonas, Biogen Idec's chief scientific officer, who also joined Biogen Idec directly from an academic role.

Dr Henderson was most recently Gurewitsch and Vidda Foundation professor of Rehabilitation and Regenerative Medicine at Columbia University in New York City. He also currently leads Target ALS, a privately-funded collaborative consortium focused on seeding ALS drug development programmes through the discovery and validation of novel therapeutic targets.

Biogen Idec Richard Ransohoff Dr Ransohoff served as director of the Neuroinflammation Research Center in the Department of Neurosciences of the Lerner Research Institute at the Clevelnad Clinic in Cleveland, Ohio.

He was also professor of Molecular Medicine at the Lerner College of Medicine at Case Western Reserve University and staff neurologist at the Mellen Center for Multiple Sclerosis Treatment and Research

“We are bringing together some of the brightest minds in research to create new ways of looking at devastating neurological diseases where there are few, if any, effective therapies,” said Dr Artavanis-Tsakonas. “Chris and Richard will help accelerate our efforts to bring innovative new medicines to patients who desperately need them.”

28th October 2014

From: Research

Share

Tags

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Porterhouse Medical Group

The Porterhouse Medical Group provides powerful, insight-driven, scientific and medical communication services to the pharmaceutical industry across the globe, with...

Latest intelligence

InSite Mapping™ - a Novel Tool for Insight-gathering and Patient Journey Mapping
Learn how a client engaged 18 rheumatologist advisors over 6 months to create a patient journey map for SLE....
Alone we can do so little, together we can do so much
Collaboration is at the heart of successful patient engagement and effective healthcare provision. But in such a complex, nuanced network, true collaborations are rare. So how can we, as an...
7 important considerations for creating an inclusive clinical trial website
You might have noticed that all of us here at COUCH Health are big advocates for taking action to improve diversity and inclusion in the world of clinical research. ‘Taking...

Infographics